ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,103.14
-0.16%
S&P 500
5,702.55
-0.19%
Dow Jones
42,063.36
0.09%
US Dollar vs Yen
143.825
0.01%
Brent Oil
74.135
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Immix Biopharma Inc (IMMX)

  7. Immix Biopharma Inc (IMMX) ニュース

IMMX

Immix Biopharma (IMMX)

Immix Biopharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:IMMX
日付受信時刻ニュースソース見出しコード企業名
2024/08/2705 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/08/2009 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/08/1306 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMMXImmix Biopharma Inc
2024/08/0110 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/07/2622 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/07/2010 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/07/2010 : 12Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMMXImmix Biopharma Inc
2024/06/1506 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/06/1022 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/06/1022 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/06/1021 : 30GlobeNewswire Inc.RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and PartnershipsNASDAQ:IMMXImmix Biopharma Inc
2024/06/0522 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/06/0522 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2205 : 05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 27Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1510 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1510 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1005 : 27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0807 : 15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0623 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/02/0606 : 38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0606 : 37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2023/12/1308 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/11/2900 : 48InvestorsHub NewsWireImmix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient DosingNASDAQ:IMMXImmix Biopharma Inc
2023/11/1009 : 57Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IMMXImmix Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:IMMX

最近閲覧した銘柄

FX
USDJPY
US Dollar vs Yen
SPI
SP500
S&P 500
AMEX
XLE
Energy Select Sector SPDR
NYSE
CVX
Chevron
CCOM
SILVER
SILVER
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
COIN
DOGEUSD
Dogecoin
NYSE
AXP
American Express
NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
USOTC
ADDYY
Adidas (QX)
COIN
XRPUSD
Ripple
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有